Stage I Breast Carcinoma Recruiting Phase 2 Trials for Talazoparib (DB11760)

Also known as: Early Breast cancer / Breast Cancer Stage I / Carcinoma Breast Stage I / Breast Cancer, Stage I / Stage I Breast Cancer / Breast carcinoma stage I / Breast carcinoma NOS stage I / Breast cancer NOS stage I

IndicationStatusPhase
DBCOND0059537 (Stage I Breast Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03499353Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast CancerTreatment